(ELIOR) Elior SCA - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0011950732
Catering, Cleaning, Maintenance, Facility, Energy
Dividends
| Dividend Yield | 1.51% |
| Yield on Cost 5y | 0.72% |
| Yield CAGR 5y | % |
| Payout Consistency | 45.8% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 46.7% |
| Value at Risk 5%th | 69.4% |
| Relative Tail Risk | -9.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -3.60 |
| CAGR/Max DD | -0.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.568 |
| Beta | 0.001 |
| Beta Downside | 0.006 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.82% |
| Mean DD | 33.26% |
| Median DD | 37.30% |
Description: ELIOR Elior SCA October 22, 2025
Elior Group SA (ticker ELIOR) is a French-based contract catering and support-services provider founded in 1991 and headquartered in Paris. Its core business delivers food-service solutions to business & industry, education, and healthcare under the Elior brand, while the Elior Services arm offers ancillary operations such as cleaning, facility management, energy-efficiency projects, and engineering subcontracting, including aerospace.
In FY 2023 the company reported revenue of roughly €5.5 billion, with an adjusted EBITDA margin around 5 %, reflecting the low-margin nature of the contract-catering sector. Key drivers include demographic aging (boosting demand for healthcare catering), inflationary pressure on food and labor costs, and increasing regulatory focus on sustainability and employee welfare in France and the EU. A material risk is the potential for tighter labor legislation to raise staffing expenses, which could compress margins if not offset by price adjustments or productivity gains.
For a deeper quantitative assessment of Elior’s valuation metrics and peer comparison, the ValueRay platform offers a free, data-rich dashboard that can help you test the assumptions outlined above.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (1.50m TTM) > 0 and > 6% of Revenue (6% = 552.9m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.20% (prev -4.79%; Δ -2.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 526.0m > Net Income 1.50m (YES >=105%, WARN >=100%) |
| Net Debt (1.11b) to EBITDA (430.5m) ratio: 2.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (252.9m) change vs 12m ago 0.07% (target <= -2.0% for YES) |
| Gross Margin 15.95% (prev 15.17%; Δ 0.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 243.2% (prev 260.4%; Δ -17.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.24 (EBITDA TTM 430.5m / Interest Expense TTM 53.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.70
| (A) -0.18 = (Total Current Assets 1.16b - Total Current Liabilities 1.82b) / Total Assets 3.77b |
| (B) 0.01 = Retained Earnings (Balance) 43.0m / Total Assets 3.77b |
| (C) 0.06 = EBIT TTM 224.5m / Avg Total Assets 3.79b |
| (D) 0.02 = Book Value of Equity 45.0m / Total Liabilities 2.95b |
| Total Rating: -0.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.44
| 1. Piotroski 5.0pt |
| 2. FCF Yield 13.77% |
| 3. FCF Margin 2.69% |
| 4. Debt/Equity 1.56 |
| 5. Debt/Ebitda 2.57 |
| 6. ROIC - WACC (= 4.09)% |
| 7. RoE 0.19% |
| 8. Rev. Trend 49.97% |
| 9. EPS Trend 51.64% |
What is the price of ELIOR shares?
As of December 14, 2025, the stock is trading at EUR 2.65 with a total of 1,203,146 shares traded.
Over the past week, the price has changed by -2.29%, over one month by -5.02%, over three months by +1.69% and over the past year by -3.64%.
Over the past week, the price has changed by -2.29%, over one month by -5.02%, over three months by +1.69% and over the past year by -3.64%.
Is ELIOR a buy, sell or hold?
Elior SCA has no consensus analysts rating.
What are the forecasts/targets for the ELIOR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.1 | 18.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.5 | -5.7% |
ELIOR Fundamental Data Overview December 12, 2025
Market Cap USD = 813.7m (695.5m EUR * 1.1701 EUR.USD)
Market Cap EUR = 695.5m (695.5m EUR * 1.0 EUR.EUR)
P/E Trailing = 8.0706
P/E Forward = 8.1633
P/S = 0.1131
P/B = 0.8165
Beta = 2.173
Revenue TTM = 9.21b EUR
EBIT TTM = 224.5m EUR
EBITDA TTM = 430.5m EUR
Long Term Debt = 885.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 277.0m EUR (from shortTermDebt, last quarter)
Debt = 1.29b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b EUR (from netDebt column, last quarter)
Enterprise Value = 1.80b EUR (695.5m + Debt 1.29b - CCE 180.0m)
Interest Coverage Ratio = 4.24 (Ebit TTM 224.5m / Interest Expense TTM 53.0m)
FCF Yield = 13.77% (FCF TTM 248.0m / Enterprise Value 1.80b)
FCF Margin = 2.69% (FCF TTM 248.0m / Revenue TTM 9.21b)
Net Margin = 0.02% (Net Income TTM 1.50m / Revenue TTM 9.21b)
Gross Margin = 15.95% ((Revenue TTM 9.21b - Cost of Revenue TTM 7.74b) / Revenue TTM)
Gross Margin QoQ = 17.40% (prev 17.40%)
Tobins Q-Ratio = 0.48 (Enterprise Value 1.80b / Total Assets 3.77b)
Interest Expense / Debt = 4.12% (Interest Expense 53.0m / Debt 1.29b)
Taxrate = 29.51% (18.0m / 61.0m)
NOPAT = 158.3m (EBIT 224.5m * (1 - 29.51%))
Current Ratio = 0.64 (Total Current Assets 1.16b / Total Current Liabilities 1.82b)
Debt / Equity = 1.56 (Debt 1.29b / totalStockholderEquity, last quarter 825.0m)
Debt / EBITDA = 2.57 (Net Debt 1.11b / EBITDA 430.5m)
Debt / FCF = 4.46 (Net Debt 1.11b / FCF TTM 248.0m)
Total Stockholder Equity = 800.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.04% (Net Income 1.50m / Total Assets 3.77b)
RoE = 0.19% (Net Income TTM 1.50m / Total Stockholder Equity 800.0m)
RoCE = 13.32% (EBIT 224.5m / Capital Employed (Equity 800.0m + L.T.Debt 885.0m))
RoIC = 8.08% (NOPAT 158.3m / Invested Capital 1.96b)
WACC = 4.00% (E(695.5m)/V(1.98b) * Re(6.02%) + D(1.29b)/V(1.98b) * Rd(4.12%) * (1-Tc(0.30)))
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.04%
[DCF Debug] Terminal Value 79.33% ; FCFE base≈225.2m ; Y1≈242.5m ; Y5≈298.5m
Fair Price DCF = 20.59 (DCF Value 5.21b / Shares Outstanding 253.1m; 5y FCF grow 8.67% → 3.0% )
EPS Correlation: 51.64 | EPS CAGR: 9.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 49.97 | Revenue CAGR: 15.54% | SUE: 3.01 | # QB: 2
EPS current Year (2026-09-30): EPS=0.36 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=-17.1% | Growth Revenue=+2.7%
EPS next Year (2027-09-30): EPS=0.43 | Chg30d=-0.025 | Revisions Net=-2 | Growth EPS=+18.6% | Growth Revenue=+3.4%
Market Cap EUR = 695.5m (695.5m EUR * 1.0 EUR.EUR)
P/E Trailing = 8.0706
P/E Forward = 8.1633
P/S = 0.1131
P/B = 0.8165
Beta = 2.173
Revenue TTM = 9.21b EUR
EBIT TTM = 224.5m EUR
EBITDA TTM = 430.5m EUR
Long Term Debt = 885.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 277.0m EUR (from shortTermDebt, last quarter)
Debt = 1.29b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b EUR (from netDebt column, last quarter)
Enterprise Value = 1.80b EUR (695.5m + Debt 1.29b - CCE 180.0m)
Interest Coverage Ratio = 4.24 (Ebit TTM 224.5m / Interest Expense TTM 53.0m)
FCF Yield = 13.77% (FCF TTM 248.0m / Enterprise Value 1.80b)
FCF Margin = 2.69% (FCF TTM 248.0m / Revenue TTM 9.21b)
Net Margin = 0.02% (Net Income TTM 1.50m / Revenue TTM 9.21b)
Gross Margin = 15.95% ((Revenue TTM 9.21b - Cost of Revenue TTM 7.74b) / Revenue TTM)
Gross Margin QoQ = 17.40% (prev 17.40%)
Tobins Q-Ratio = 0.48 (Enterprise Value 1.80b / Total Assets 3.77b)
Interest Expense / Debt = 4.12% (Interest Expense 53.0m / Debt 1.29b)
Taxrate = 29.51% (18.0m / 61.0m)
NOPAT = 158.3m (EBIT 224.5m * (1 - 29.51%))
Current Ratio = 0.64 (Total Current Assets 1.16b / Total Current Liabilities 1.82b)
Debt / Equity = 1.56 (Debt 1.29b / totalStockholderEquity, last quarter 825.0m)
Debt / EBITDA = 2.57 (Net Debt 1.11b / EBITDA 430.5m)
Debt / FCF = 4.46 (Net Debt 1.11b / FCF TTM 248.0m)
Total Stockholder Equity = 800.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.04% (Net Income 1.50m / Total Assets 3.77b)
RoE = 0.19% (Net Income TTM 1.50m / Total Stockholder Equity 800.0m)
RoCE = 13.32% (EBIT 224.5m / Capital Employed (Equity 800.0m + L.T.Debt 885.0m))
RoIC = 8.08% (NOPAT 158.3m / Invested Capital 1.96b)
WACC = 4.00% (E(695.5m)/V(1.98b) * Re(6.02%) + D(1.29b)/V(1.98b) * Rd(4.12%) * (1-Tc(0.30)))
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.04%
[DCF Debug] Terminal Value 79.33% ; FCFE base≈225.2m ; Y1≈242.5m ; Y5≈298.5m
Fair Price DCF = 20.59 (DCF Value 5.21b / Shares Outstanding 253.1m; 5y FCF grow 8.67% → 3.0% )
EPS Correlation: 51.64 | EPS CAGR: 9.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 49.97 | Revenue CAGR: 15.54% | SUE: 3.01 | # QB: 2
EPS current Year (2026-09-30): EPS=0.36 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=-17.1% | Growth Revenue=+2.7%
EPS next Year (2027-09-30): EPS=0.43 | Chg30d=-0.025 | Revisions Net=-2 | Growth EPS=+18.6% | Growth Revenue=+3.4%